CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.61−0.02 (-3.60%)
Close on Nov 13, 2026Market cap $16.18MP/E –Yield –
CVRx EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
CVRx's EPS for the twelve months ending Sep 30, 2026 was -$2.01. For fiscal 2025 it was -$2.04. The highest annual figure on record is -$1.99 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.04 | – |
| FY2024 | Dec 31, 2024 | -$2.65 | – |
| FY2023 | Dec 31, 2023 | -$1.99 | – |
| FY2022 | Dec 31, 2022 | -$2.02 | – |
| FY2021 | Dec 31, 2021 | -$4.16 | – |
| FY2020 | Dec 31, 2020 | -$37.01 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.52 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.53 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.50 | – |
| Q4 FY2025 | Dec 31, 2025 | -$0.46 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.49 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.57 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.53 | – |
| Q4 FY2024 | Dec 31, 2024 | -$0.43 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.57 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.65 | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.04 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.44 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.43 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.56 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.55 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.51 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.48 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.54 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.49 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.30 | – |
| Q2 FY2021 | Jun 30, 2021 | -$48.48 | – |
| Q1 FY2021 | Mar 31, 2021 | -$23.92 | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.45 | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.56 | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.18 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?